ZEMDRI - Ownership and Business Overview

Life ScienceCompany

ZEMDRI Ownership

Who owns ZEMDRI?

ZEMDRI is owned by Cipla. It was acquired on July 24, 2019.

ZEMDRI Business Overview

Where is ZEMDRI headquartered?

ZEMDRI is headquartered in San Francisco, California.

What sector is ZEMDRI in?

ZEMDRI is a life science company.

When was ZEMDRI founded?

ZEMDRI was founded in 2018.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 245 acquisitions of life science companies in 2019, including 40 acquisitions by private equity firms, and 205 by strategics.

ZEMDRI (Plazomicin)

San Francisco, California 94080
United States,
www.zemdri.com

ZEMDRI (Plazomicin) is a once-daily novel intravenous (IV) aminoglycoside for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis, in adults who are unresponsive to currently available treatment options. ZEMDRI™ was approved by the United States Food & Drug Administration (USFDA) in June 2018 and was launched in the same year, with patent protection expected to continue until 2031 or 2032.


 Subscribe to unlock this and 202,005
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.